000 02327cam a2200289zu 4500
001 88964211
003 FRCYB88964211
005 20250429182656.0
006 m o d
007 cr un
008 250429s2022 fr | o|||||0|0|||eng d
020 _a9780128226209
035 _aFRCYB88964211
040 _aFR-PaCSA
_ben
_c
_erda
100 1 _aJewett, Anahid
245 0 1 _aNK Cells in Cancer Immunotherapy: Successes and Challenges
_c['Jewett, Anahid', 'Fong Md, Facs, Yuman']
264 1 _bAcademic Press
_c2022
300 _a p.
336 _btxt
_2rdacontent
337 _bc
_2rdamdedia
338 _bc
_2rdacarrier
650 0 _a
700 0 _aJewett, Anahid
700 0 _aFong Md, Facs, Yuman
856 4 0 _2Cyberlibris
_uhttps://international.scholarvox.com/netsen/book/88964211
_qtext/html
_a
520 _aNK Cells in Cancer Immunotherapy: Successes and Challenges explains the latest immunotherapeutic strategies, focusing on NK cells to allow the best and precise combination treatments to cancer patients. The book provides existing background knowledge in the field of immunotherapy and discusses future areas of research required to carry out cutting-edge, validated therapies. Chapters cover advances in immunotherapeutic strategies, in particular, the use of NK cells with and without T-cell therapy in the treatment of cancer. The book is a valuable resource for cancer researchers, oncologists, graduate students and those interested in learning more about novel strategies to treat cancer patients. Immunotherapy is fast becoming the method of choice for cancer therapy. Although remarkable advances have been made in the field of immunotherapy, there are significant challenges and difficulties ahead since many of the current immunotherapeutic strategies do not provide long-lasting treatment strategies, and therefore are not very effective. - Covers CAR/T and CAR/NK and adoptive NK cell therapy with and without T cell therapies - Discusses basic biology of NK cells and mouse models of human cancers and the role of NK cells in metastatic cancer and in cancer stem cells - Encompasses information on combination therapies using check point inhibition, adoptive transfer of cytotoxic effector cells, chemotherapeutic drugs and activating and inhibitory antibodies
999 _c1327650
_d1327650